Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
3D Systems | DDD | Apr 26, 2024 | 3.43 | 0.00 |
3M | MMM | Apr 26, 2024 | 91.83 | +0.46 |
4D Molecular Therapeutics | FDMT | Apr 26, 2024 | 23.25 | -1.19 |
51Talk Online Education Group ADR | COE | Apr 26, 2024 | 6.61 | +2.96 |
5E Advanced Materials | FEAM | Apr 26, 2024 | 1.13 | +1.80 |
60 Degrees Pharmaceuticals | SXTP | Apr 26, 2024 | 0.24 | +1.71 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Apr 26, 2024 | 15.48 | -0.33 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Apr 26, 2024 | 23.47 | +0.66 |
7-10 Yr Trsy Ishares | IEF | Apr 26, 2024 | 91.49 | +0.27 |
89bio | ETNB | Apr 26, 2024 | 8.26 | +0.12 |
8x8 | EGHT | Apr 26, 2024 | 2.27 | -2.16 |
908 Devices | MASS | Apr 26, 2024 | 5.67 | +1.98 |
99 Acquisition Group | NNAG | Apr 26, 2024 | 10.39 | -0.10 |
99 Acquisition Group | NNAGU | Apr 26, 2024 | 10.61 | 0.00 |
9F ADR | JFU | Apr 26, 2024 | 3.12 | -8.37 |
A SPAC I Acquisition Unit | ASCAU | Apr 26, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | Apr 26, 2024 | 11.14 | +0.54 |
A-Mark Precious Metals | AMRK | Apr 26, 2024 | 40.12 | +4.10 |
a.k.a Brands | AKA | Apr 26, 2024 | 12.75 | +1.03 |
A.O Smith | AOS | Apr 26, 2024 | 83.21 | +0.47 |
A10 Networks | ATEN | Apr 26, 2024 | 13.54 | -0.29 |
A2Z Smart Technologies | AZ | Apr 26, 2024 | 0.39 | -3.69 |
AAA - A Rated Corporate Bond Ishares | QLTA | Apr 26, 2024 | 46.13 | +0.22 |
Aadi Bioscience | AADI | Apr 26, 2024 | 1.75 | +4.17 |
AAON | AAON | Apr 26, 2024 | 91.15 | +1.39 |
AAR | AIR | Apr 26, 2024 | 68.27 | +1.26 |
Abacus Life | ABL | Apr 26, 2024 | 11.93 | -0.42 |
Abbott Laboratories | ABT | Apr 26, 2024 | 107.53 | +0.63 |
AbbVie | ABBV | Apr 26, 2024 | 159.62 | -4.58 |
AbCellera Biologics | ABCL | Apr 26, 2024 | 3.76 | +3.58 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.